🔎 Trials Near Me

Akèy › Kansè Selil Plazmatik › Kalifòni

Etid klinik pou Kansè Selil Plazmatik nan Kalifòni

3 etid pou Kansè Selil Plazmatik ap chèche patisipan nan sit nan Kalifòni.

Tèks ofisyèl etid la (Anglè)

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

  • Beverly Hills Cancer Center, Beverly Hills
  • Clovis Community Medical Center, Clovis
  • Community Cancer Institute, Clovis
  • ak 9 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT06152575

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

  • UCSF Medical Center - Hematology and Blood and Marrow Transplant Clinic, San Francisco
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT05651932

Delayed Toxicities Post-CAR-T

  • UCSF Medical Center, San Francisco
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT07665307

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.